Skip to main content
NIH funding notice PAR-22-099

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Closed on November 23, 2024.

Posted
January 21, 2022
Close date
November 23, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,044,549 in first-year total cost, median $506,445.

Most frequent study sections

  1. Cellular and Molecular Technologies Study Section[CMT]3
  2. Biomaterials and Biointerfaces Study Section[BMBI]2
  3. Tumor Host Interactions Study Section[THI]2
  4. Developmental Therapeutics Study Section[DT]1
  5. Special Emphasis Panel[ZRG1 BTC-D (02)]1

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. CORNELL UNIVERSITY1
  3. JOHNS HOPKINS UNIVERSITY1
  4. PURDUE UNIVERSITY1
  5. SANFORD RESEARCH/USD1
Competing awards under PAR-22-099 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Elucidating spatiotemporal dynamics of nascent extracellular matrix in response to platinum treatment in ovarian cancer1R37CA291976-01A1DE LA PUENTE, PILARSANFORD RESEARCH/USD, SD$584,081CMT
2024Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer2R01CA240301-06BURDETTE, JOANNA ECOPPETA, JONATHANUNIVERSITY OF ILLINOIS AT CHICAGO, IL$622,570ZRG1
2024Tissue engineered organ-specific cancer metastasis model for cancer research1R01CA292382-01WANG, ANDREW ZHUANGUT SOUTHWESTERN MEDICAL CENTER, TX$544,475CMT
2024Engineering the Premetastatic Niche1R01CA281216-01A1SOLORIO, LUISWENDT, MICHAEL KEITHPURDUE UNIVERSITY, IN$521,240ZRG1
2024Investigating the role of metabolic rewiring in breast tumor innervation1R37CA279722-01A1SONG, YOUNGHYEUNIVERSITY OF ARKANSAS AT FAYETTEVILLE, AR$511,284THI
2024A vascularized microphysiological system (MPS) platform for modeling peritoneal carcinomatosis1R01CA290115-01HUGHES, CHRISTOPHER C. W.SENTHIL, MAHESWARIUNIVERSITY OF CALIFORNIA-IRVINE, CA$501,606CMT
2024Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents1R01CA279948-01A1AHN, EUN HYUNKIM, DEOK-HOJOHNS HOPKINS UNIVERSITY, MD$443,191BMBI
2023A novel breast cancer therapy based on secreted protein ligands from CD36+ fibroblasts1R01CA279408-01PARVIN, BAHRAM A.UNIVERSITY OF NEVADA RENO, NV$459,309DT
2023A Bioprinted Volumetric Model of Vascularized Glioblastoma1R01CA282451-01QUINONES-HINOJOSA, ALFREDOZHANG, Y. SHRIKEBRIGHAM AND WOMEN'S HOSPITAL, MA$446,380BMBI
2023Tissue-Engineered Models of Lymphatic Drainage in Breast Cancer1R01CA279560-01LEE, ESAKCORNELL UNIVERSITY, NY$410,413THI

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.